IN190388B - - Google Patents

Info

Publication number
IN190388B
IN190388B IN2930DE1998A IN190388B IN 190388 B IN190388 B IN 190388B IN 2930DE1998 A IN2930DE1998 A IN 2930DE1998A IN 190388 B IN190388 B IN 190388B
Authority
IN
India
Prior art keywords
active compound
biologically active
vesicles
mlcvs
multilamellar
Prior art date
Application number
Other languages
English (en)
Inventor
Lawrence Boni
Michael Batenjany
Stella Gevantmakher
Original Assignee
Biomira Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Usa Inc filed Critical Biomira Usa Inc
Publication of IN190388B publication Critical patent/IN190388B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN2930DE1998 1997-10-01 1998-01-01 IN190388B (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6060697P 1997-10-01 1997-10-01

Publications (1)

Publication Number Publication Date
IN190388B true IN190388B (ja) 2003-07-26

Family

ID=22030591

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2930DE1998 IN190388B (ja) 1997-10-01 1998-01-01

Country Status (9)

Country Link
US (1) US6544549B1 (ja)
EP (1) EP1019026B1 (ja)
JP (1) JP2001517693A (ja)
AT (1) ATE286717T1 (ja)
AU (1) AU745000B2 (ja)
CA (1) CA2305533C (ja)
DE (1) DE69828624T2 (ja)
IN (1) IN190388B (ja)
WO (1) WO1999016426A2 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1857112B1 (en) * 2005-03-09 2013-05-15 Sunstar Inc. Anticancer composition comprising liposomes containing phytosterols
US7662405B2 (en) * 2005-08-09 2010-02-16 The Research Foundation Of State University Of New York Compositions and methods of preparation of liposomal microparticulate IL-12
ES2625111T3 (es) 2005-12-30 2017-07-18 Nuvessl Inc. Partículas nanolipídicas
US20140271782A1 (en) 2013-03-15 2014-09-18 Dermazone Solutions, Inc. Method for preparing nanolipids with encapsulated alcohol
EP2398466B1 (en) 2008-11-24 2021-02-17 Massachusetts Institute of Technology Methods and compositions for localized nanoparticle delivery to a tumor
US20100323018A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Branched DNA/RNA monomers and uses thereof
US20100324124A1 (en) * 2009-06-17 2010-12-23 Massachusetts Institute Of Technology Compositions and methods relating to DNA-based particles
US20110229556A1 (en) * 2010-03-19 2011-09-22 Massachusetts Institute Of Technology Lipid-coated polymer particles for immune stimulation
SG184127A1 (en) 2010-03-19 2012-10-30 Massachusetts Inst Technology Lipid vesicle compositions and methods of use
US9149432B2 (en) 2010-03-19 2015-10-06 Massachusetts Institute Of Technology Lipid vesicle compositions and methods of use
CN102654505A (zh) * 2012-05-16 2012-09-05 江苏省原子医学研究所 一种检测il-2-hsa的时间分辨荧光免疫分析试剂盒及其检测方法
US10639367B2 (en) * 2012-11-02 2020-05-05 Cytuvax Composition comprising cytokine macro-aggregates
US9770415B2 (en) * 2012-11-27 2017-09-26 Southwest Research Institute Delivery substrates from aligned polymer biomaterials for tissue repair
ES2904276T3 (es) 2013-09-27 2022-04-04 Massachusetts Inst Technology Nanoestructuras de proteínas biológicamente activas sin vehículo
EP3291797B1 (en) 2015-05-04 2020-09-02 Versantis AG Method for preparing transmembrane ph-gradient vesicles
AU2016305087B2 (en) 2015-08-12 2022-01-20 Massachusetts Institute Of Technology Cell surface coupling of nanoparticles
EP3468581A1 (en) 2016-06-13 2019-04-17 Torque Therapeutics, Inc. Methods and compositions for promoting immune cell function
AU2018328209A1 (en) 2017-09-05 2020-04-23 Torque Therapeutics, Inc. Therapeutic protein compositions and methods of making and using the same
US20200078316A1 (en) 2018-09-06 2020-03-12 NuVessl, Inc. Method of Using Cannabinoids Encapsulated in Phospholipid Carriers for Transmucosal and Transdermal Administration
US11458092B2 (en) 2018-12-14 2022-10-04 NuVessl, Inc. Composition with enhanced passenger molecule loading
WO2021158996A1 (en) * 2020-02-05 2021-08-12 University Of Florida Research Foundation, Incorporated Rna-loaded nanoparticles and use thereof for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04356421A (ja) 1991-03-06 1992-12-10 Green Cross Corp:The プロスタグランジン類含有脂肪小体組成物
EP0918539B1 (en) * 1996-02-16 2005-10-19 Biomira Usa Inc. Vaccine for b-cell malignancies

Also Published As

Publication number Publication date
EP1019026B1 (en) 2005-01-12
CA2305533C (en) 2009-12-01
US6544549B1 (en) 2003-04-08
AU9680098A (en) 1999-04-23
WO1999016426A3 (en) 1999-06-17
AU745000B2 (en) 2002-03-07
CA2305533A1 (en) 1999-04-08
DE69828624T2 (de) 2005-12-22
WO1999016426A2 (en) 1999-04-08
ATE286717T1 (de) 2005-01-15
DE69828624D1 (de) 2005-02-17
JP2001517693A (ja) 2001-10-09
EP1019026A2 (en) 2000-07-19

Similar Documents

Publication Publication Date Title
IN190388B (ja)
ATE341310T1 (de) Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
WO2000045791A3 (en) Method for controlling liposome size
AU8141891A (en) Unilamellar vesicles
AU6036596A (en) Process for making liposome preparation
HUP9802578A3 (en) Phenylacetic acid derivatives, process and intermediates for producing them, fingicide, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients and use thereof
CA2108288A1 (en) Liposomal cyclosporin formulation and process for the preparation thereof
CA2192190A1 (en) Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
JP2001517693A5 (ja)
CA2187748A1 (en) Fusogenic liposomes and methods of making and using same
MY131524A (en) Liposomal itraconazole formulations
IE800235L (en) Tricyclic pyrazoles
CA2202103A1 (en) Method for preparing closed vesicles
CA2118529A1 (en) Method for applying debonding materials to a tissue
GB2303791A (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
AU7593391A (en) Process for the production of aqueous liposome suspensions containing active ingredients
CA2101325A1 (en) Cell-free and whole cell ice nucleators and process for their production
WO1999049716A3 (de) Verfahren zur herstellung von liposomalen wirkstoffformulierungen mit hochdruckhomogemisation
DE3851842D1 (de) Wässrige bereitung von liposomenzusammensetzungen.
CA2402364A1 (en) Process for producing camptothecin
WO2003059279A3 (en) Efficient liposomal encapsulation under mild conditions
JPS5344559A (en) New urethanes and their preparation
ES2105974A1 (es) Composicion liposomal para la hidratacion intensiva de la piel.
ES2168351T3 (es) Preparaciones farmaceuticas que contienen nifedipina y procedimiento para su preparacion.